JANE STREET GROUP, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2024$44,391
-63.4%
28,456
-54.2%
0.00%
Q1 2024$121,173
+317.8%
62,140
+511.8%
0.00%
Q2 2022$29,000
-71.6%
10,157
-25.9%
0.00%
Q4 2021$102,000
-96.9%
13,700
-96.2%
0.00%
-100.0%
Q3 2021$3,267,000359,9010.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 179,308$875,0001.20%
Ikarian Capital, LLC 300,000$1,465,0000.12%
Alyeska Investment Group, L.P. 1,274,747$6,221,0000.07%
XTX Topco Ltd 12,265$60,0000.02%
FEDERATED HERMES, INC. 1,615,000$7,881,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 32,430$158,0000.01%
TWO SIGMA ADVISERS, LP 119,950$585,0000.00%
FMR LLC 1,675,880$8,178,0000.00%
Renaissance Technologies 176,255$860,0000.00%
ACADIAN ASSET MANAGEMENT LLC 42,724$208,0000.00%
View complete list of ATYR PHARMA INC shareholders